An interventional study of Dynatronics VF5 Model vibration platform and Placebo Dynatronics VF5 Model vibration platform in Bone Density and Muscle Weakness, sponsored by Jouf University. Not yet recruiting at 1 site in Saudi Arabia. Open to male participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-18.
Sponsored by Jouf University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study aims of this clinical trial is to evaluate the effect of an 8-week Whole Body Vibration (WBV) intervention on Bone Mineral Density (BMD), hand grip strength, and vitamin D levels in middle-aged men. Findings from this study will contribute to understanding whether WBV is a viable alternative to conventional exercise, especially for those with limitations in physical activity.
Study Objectives:
478 studies on the registry are indexed under Muscle Weakness; 72 are open to participants now.
This study's planned enrollment of 34 is below the median of 44 across 364 interventional studies indexed under Muscle Weakness.
Browse Muscle Weakness studies →Jouf University is the lead sponsor of 22 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will perform the same activities as the experimental group, but with a vertical displacement of 0.22 mm, deemed therapeutically insufficient.
Device: Placebo Dynatronics VF5 Model vibration platform
Participants will undergo an 8-week WBV therapy program using a Dynatronics VF5 Model vibration platform. Each session will last 4 minutes, with vibration frequencies progressively increased from 25 Hz to 40 Hz without rest intervals.
Device: Dynatronics VF5 Model vibration platform
The Dynatronics VF5 Model vibration platform is a specialized therapeutic device designed for rehabilitation and wellness applications. Utilizing advanced vibration technology, it provides whole-body vibration therapy that can enhance muscle strength, improve flexibility, and promote overall physical well-being. The platform features adjustable frequency and amplitude settings, allowing customization based on individual needs. Its user-friendly interface and robust, durable design make it suitable for both clinical and mobile therapy settings. Additionally, the compact and portable nature of the VF5 facilitates easy storage and transport, while safety features such as non-slip surfaces ensure user protection.
Placebo intensity with vertical vibration of 0.2 mm
Bone Density
Changes in BMD (measured by DXA scanner),
Time frame: 8 weeks
Grip Strength
hand grip strength (measured by a hand-held dynamometer)
Time frame: 8 weeks
Vitamin D
Vitamin D levels (measured by high-performance liquid chromatography).
Time frame: 8 weeks
Plan to share: Yes — all IPD that underlie results in a publication
Supporting information: Study protocol
No publications or documents are linked to this record.
Start is estimated for Oct 2024; primary completion for Dec 2024, 1 month later.
Of 200 non-industry interventional studies with no phase under Muscle Weakness, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 1 month is below that.
Counting every sponsor, half of 212 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jouf University